tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Early Komzifti Traction and Clinical Catalysts Underpin Buy Rating and 2028 Growth Outlook
PremiumRatingsEarly Komzifti Traction and Clinical Catalysts Underpin Buy Rating and 2028 Growth Outlook
18d ago
Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating
Premium
Ratings
Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating
18d ago
Kura Oncology reports Q4 EPS (92c), consensus (49c)
Premium
The Fly
Kura Oncology reports Q4 EPS (92c), consensus (49c)
18d ago
Kura Oncology Tightens Governance with Amended Bylaws
PremiumCompany AnnouncementsKura Oncology Tightens Governance with Amended Bylaws
2M ago
3 ‘Strong Buy’ Biotech Stocks to Buy Today, 1/13/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Today, 1/13/2026, According to Top Analysts
2M ago
Kura Oncology price target lowered to $20 from $25 at Leerink
Premium
The Fly
Kura Oncology price target lowered to $20 from $25 at Leerink
2M ago
Kura Oncology Announces First U.S. Sale of KOMZIFTI
PremiumCompany AnnouncementsKura Oncology Announces First U.S. Sale of KOMZIFTI
4M ago
Kura Oncology completes first U.S. commercial sale of KOMZIFTI
Premium
The Fly
Kura Oncology completes first U.S. commercial sale of KOMZIFTI
4M ago
Kura Oncology’s Growth Potential Boosted by KOMZIFTI’s NCCN Inclusion and Competitive Advantages
Premium
Ratings
Kura Oncology’s Growth Potential Boosted by KOMZIFTI’s NCCN Inclusion and Competitive Advantages
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100